These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 3173334

  • 1. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
    Peroutka SJ, Hamik A, Harrington MA, Hoffman AJ, Mathis CA, Pierce PA, Wang SS.
    Mol Pharmacol; 1988 Oct; 34(4):537-42. PubMed ID: 3173334
    [Abstract] [Full Text] [Related]

  • 2. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA, Davis KH, Titeler M.
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [Abstract] [Full Text] [Related]

  • 3. R(-)-2,5-dimethoxy-4-77 bromoamphetamine [77Br-R(-)DOB]: a novel radioligand which labels a 5-HT binding site subtype.
    Wang SS, Mathis CA, Peroutka SJ.
    Psychopharmacology (Berl); 1988 Feb; 94(3):431-2. PubMed ID: 3357926
    [Abstract] [Full Text] [Related]

  • 4. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
    Branchek T, Adham N, Macchi M, Kao HT, Hartig PR.
    Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697
    [Abstract] [Full Text] [Related]

  • 5. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
    McKenna DJ, Peroutka SJ.
    J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135
    [Abstract] [Full Text] [Related]

  • 6. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
    Pranzatelli MR, Murthy JN, Pluchino RS.
    J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361
    [Abstract] [Full Text] [Related]

  • 7. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M, Lyon RA, Davis KH, Glennon RA.
    Biochem Pharmacol; 1987 Oct 01; 36(19):3265-71. PubMed ID: 3663239
    [Abstract] [Full Text] [Related]

  • 8. Evidence for distinct 5-hydroxytryptamine2 binding site subtypes in cortical membrane preparations.
    Pierce PA, Peroutka SJ.
    J Neurochem; 1989 Feb 01; 52(2):656-8. PubMed ID: 2911036
    [Abstract] [Full Text] [Related]

  • 9. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR, Gregory CM.
    Cytobios; 1993 Feb 01; 75(302-303):197-209. PubMed ID: 8243108
    [Abstract] [Full Text] [Related]

  • 10. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
    Hamblin MW, Ariani K, Adriaenssens PI, Ciaranello RD.
    J Pharmacol Exp Ther; 1987 Dec 01; 243(3):989-1001. PubMed ID: 2826763
    [Abstract] [Full Text] [Related]

  • 11. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
    Stratford CA, Tan GL, Hamblin MW, Ciaranello RD.
    Mol Pharmacol; 1988 Oct 01; 34(4):527-36. PubMed ID: 3139989
    [Abstract] [Full Text] [Related]

  • 12. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
    Hoyer D, Neijt HC.
    Mol Pharmacol; 1988 Mar 01; 33(3):303-9. PubMed ID: 3352595
    [Abstract] [Full Text] [Related]

  • 13. Hallucinogens and serotonergic mechanisms.
    Glennon RA, Teitler M, Sanders-Bush E.
    NIDA Res Monogr; 1992 Mar 01; 119():131-5. PubMed ID: 1435968
    [Abstract] [Full Text] [Related]

  • 14. Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.
    Pierce PA, Peroutka SJ.
    Psychopharmacology (Berl); 1989 Mar 01; 97(1):118-22. PubMed ID: 2540505
    [Abstract] [Full Text] [Related]

  • 15. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
    Titeler M, Lyon RA, Glennon RA.
    Psychopharmacology (Berl); 1988 Mar 01; 94(2):213-6. PubMed ID: 3127847
    [Abstract] [Full Text] [Related]

  • 16. Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
    Glennon RA, Bondarev ML, Khorana N, Young R, May JA, Hellberg MR, McLaughlin MA, Sharif NA.
    J Med Chem; 2004 Nov 18; 47(24):6034-41. PubMed ID: 15537358
    [Abstract] [Full Text] [Related]

  • 17. [3H]ketanserin labels serotonin 5-HT2 and alpha 1-adrenergic receptors in human brain cortex.
    Hoyer D, Vos P, Closse A, Palacios JM, Engel G, Davies H.
    J Cardiovasc Pharmacol; 1987 Nov 18; 10 Suppl 3():S48-50. PubMed ID: 2446070
    [Abstract] [Full Text] [Related]

  • 18. Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
    Sleight AJ, Stam NJ, Mutel V, Vanderheyden PM.
    Biochem Pharmacol; 1996 Jan 12; 51(1):71-6. PubMed ID: 8534270
    [Abstract] [Full Text] [Related]

  • 19. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
    Zhang ZJ, Trivedi BL, de Paulis T, Schmidt DE, Hewlett WA.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb 12; 365(2):123-32. PubMed ID: 11819030
    [Abstract] [Full Text] [Related]

  • 20. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
    Teitler M, Leonhardt S, Weisberg EL, Hoffman BJ.
    Mol Pharmacol; 1990 Nov 12; 38(5):594-8. PubMed ID: 2233696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.